Market Overview

Morgan Keegan Maintains Outperform on athenahealth


Morgan Keegan is out with its report today on athenahealth (NASDAQ: ATHN), maintaining Outperform.

In a note to clients, Morgan Keegan writes, "While ATHN has shown a willingness to ramp sales and marketing spend as a percentage of revenue to sustain its 30% top line growth, we believe the company should not have to do that beyond 2011."

Morgan Keegan maintains a $60 PT on ATHN.

Shares of ATHN closed Tuesday at $41.04.


Related Articles (ATHN)

View Comments and Join the Discussion!

Posted-In: athenahealth Morgan KeeganAnalyst Color Analyst Ratings

Latest Ratings

TRGPMorgan StanleyUpgrades
PAGPMorgan StanleyUpgrades
PAAMorgan StanleyUpgrades
MIKWells FargoMaintains9.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at